Le Lézard
Classified in: Science and technology, Business
Subject: TNM

Argmax Acquires AI Startup Ginzi to Bolster Customer Support Solutions


TEL AVIV, Israel, April 15, 2024 /PRNewswire/ -- Argmax, a leader in AI service provision, is proud to announce the acquisition of Ginzi, an innovative startup specializing in AI solutions for customer support teams. This strategic acquisition marks a significant expansion in Argmax's footprint in the AI industry.

Ginzi, which emerged from stealth mode just 11 months ago, has developed groundbreaking technology that revolutionizes how customer support teams interact with AI, enabling them to address each inquiry uniquely and efficiently. Ginzi was founded by Ben Jacobs and Kobi Agi and was backed by notable investors including Jumpspeed Ventures, Fresh.Fund, and Atooro Fund, Ginzi has raised $1.5 million to date. The financial details of the acquisition remain undisclosed. Additionally, the Ginzi development team is set to make a transition to Argmax.

The acquisition of Ginzi by Argmax represents a strategic expansion of Argmax's offerings in the AI industry. Ginzi's innovative AI technology for customer support teams, complements and enhances Argmax's existing services. This integration allows Argmax to offer more sophisticated, AI-driven solutions to its clients, catering to a wider range of customer support needs with greater efficiency and personalization.

The Ginzi Platform will enable Argmax to deliver a more comprehensive suite of services, setting new industry standards in AI-powered customer support. The merger not only broadens Argmax's capabilities but also solidifies its position as a leader in AI innovation, opening up new avenues for growth and development in this rapidly evolving sector.

The development team from Ginzi will be integrated into Argmax, enhancing the company's talent pool and capabilities.

"At Argmax, we are continuously strengthening our position in the AI sector," states Uri Goren, CEO of Argmax.

"The rapid evolution of AI technologies is reshaping the market, and Ginzi's innovative products and technology are at the forefront of these developments. Acquiring Ginzi allows us to enhance our market presence significantly. Ginzi's achievements in customer support are remarkable, and we are excited to build on their success."

"Argmax is perfectly placed to take the Ginzi products to new levels," said Ben Jacobs, CEO & Co-founder of Ginzi. "It's an opportunity to thank our amazing investors and team who have been extremely supportive throughout the journey."

About Argmax:
Argmax, a leader in AI services, excels in utilizing artificial intelligence to align user needs with opportunities, particularly in advertising, marketing, and financial sectors. Their innovative AI algorithms are tailored to enhance customer engagement and optimize business efficiency.

SOURCE Argmax


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: